Patents by Inventor Tatsuya NISHIMARU

Tatsuya NISHIMARU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Acylsulfamide Compound and Pharmaceutical Use Therefor
    Publication number: 20230399319
    Abstract: An acylsulfamide compound, or a pharmaceutically acceptable salt thereof, having NLRP3 inflammasome inhibitory activity, a pharmaceutical composition comprising the same, and their medical use, etc., are provided. A compound of Formula [Ia]: or a pharmaceutically acceptable salt thereof, wherein a partial structure: is: Ring Cy is an optionally substituted heteroaryl or phenyl; RDy and REy are each independently hydrogen, optionally substituted C1-6 alkyl, optionally substituted C1-4 haloalkyl, optionally substituted C3-6 cycloalkyl, optionally substituted heterocycloalkyl, or optionally substituted heteroaryl, or alternatively, RDy and REy may combine together with the nitrogen atom to which they attach to form heterocycloalkyl, etc.
    Type: Application
    Filed: December 25, 2020
    Publication date: December 14, 2023
    Inventors: Yusuke OHBA, Takayuki FURUKAWA, Kaoru ADACHI, Tatsuya NISHIMARU, Kentaro SAKURAI, Ritsuki MASUO, Tasuku INAMI
  • Nitrogen-containing heteroaryl compound and pharmaceutical use thereof
    Patent number: 10752596
    Abstract: The invention provides a compound having a GLUT9 inhibitory activity. The compound is of Formula [I] wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: October 3, 2018
    Date of Patent: August 25, 2020
    Assignee: JAPAN TOBACCO INC.
    Inventors: Hironobu Nagamori, Tatsuya Nishimaru, Masaki Takagi, Ikuo Mitani, Yuichi Nakagawa
  • NITROGEN-CONTAINING HETEROARYL COMPOUND AND PHARMACEUTICAL USE THEREOF
    Publication number: 20190152926
    Abstract: The invention provides a compound having a GLUT9 inhibitory activity. The compound is of Formula [I] wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: October 3, 2018
    Publication date: May 23, 2019
    Applicant: JAPAN TOBACCO INC.
    Inventors: Hironobu NAGAMORI, Tatsuya NISHIMARU, Masaki TAKAGI, Ikuo MITANI, Yuichi NAKAGAWA